MII IG Medikation
2027.0.0-ballot - Germany

This page is part of the MII Implementation Guide MII IG Medikation (v2027.0.0-ballot: 2027 Ballot 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Beispiel MedicationStatement: mii-exa-medikation-medication-statement-caelyx

German

status: Active

medication: Medication Caelyx pegylated liposomal 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung 1x25ml DSF N1

subject: Max Mustermann Male, DoB: 1965-03-14 ( https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/sid/patient#12345)

effective: 2020-01-02 09:30:00+0100

dosage

timing: Once per 4 weeks

route: Intravenous use

DoseAndRates

-Dose[x]
*50 mg/m2 (Details: UCUM codemg/m2 = 'mg/m2')